Arneric, S P <br/><br/>
(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.  [electronic resource] 

 -  The Journal of pharmacology and experimental therapeutics  Jul 1994 
 - 310-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0022-3565 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alkaloids--metabolism<br/>Animals<br/>Anti-Anxiety Agents--pharmacology<br/>Azocines<br/>Binding, Competitive<br/>Cognition--drug effects<br/>Corpus Striatum--drug effects<br/>Dopamine--metabolism<br/>Ion Channels--drug effects<br/>Isoxazoles--metabolism<br/>Kinetics<br/>Male<br/>Mice<br/>Nicotine--metabolism<br/>PC12 Cells<br/>Parasympathomimetics--metabolism<br/>Pyrrolidines--metabolism<br/>Quinolizines<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Cholinergic--drug effects<br/>Receptors, Nicotinic--drug effects<br/>Rubidium--pharmacokinetics<br/>Rubidium Radioisotopes<br/>Tritium